Mefloquine has more adverse effects than other drugs for malaria prophylaxisBMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b4167 (Published 13 October 2009) Cite this as: BMJ 2009;339:b4167
- Lynn Eaton
Researchers for the Cochrane Collaboration have found that mefloquine (Lariam) has more adverse effects than the two main alternatives for antimalaria prophylaxis.
They looked at prophylactic regimens for visitors to countries where Plasmodium falciparum has developed resistance to chloroquine (Cochrane Database of Systematic Reviews 2009;(4):CD006491, doi:10.1002/14651858.CD006491.pub2). Their review looked at the efficacy, safety, and tolerability of three regimens: atovaquone-proguanil (Malarone), doxycycline, and mefloquine.
On safety, the authors said that the main problem …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial